hero section gradient
14 handpicked stocks

Paywalling the Robots

As Cloudflare blocks AI crawlers by default, companies with valuable digital libraries can now charge AI developers for access to their content. This carefully selected group of stocks features businesses positioned to create new revenue streams in the emerging data licensing economy.

Author avatar

Han Tan | Market Analyst

Published on July 2

Your Basket's Financial Footprint

Concise interpretation of the basket's market capitalisation and investor takeaways, compliant with FCA guidelines.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and returns that tend to track broad-market movements.
  • Suitable as a core, diversified holding rather than a speculative trade, for balanced portfolio exposure.
  • Likely to deliver steady long-term value rather than explosive short-term gains.
Total Market Cap
  • GETY: $829.62M

  • SSTK: $917.03M

  • NWSA: $15.56B

  • Other
≈

About This Group of Stocks

1

Our Expert Thinking

These stocks represent a fundamental shift in internet economics. With Cloudflare's new Pay Per Crawl system, companies that own valuable content libraries can now monetize their digital assets by charging AI developers for training data, creating entirely new revenue streams.

2

What You Need to Know

This group includes diverse content owners (news publishers, image libraries, video archives), technology facilitators, and infrastructure providers. They're positioned to benefit from a new marketplace where AI companies must pay to access the high-quality data needed to train their models.

3

Why These Stocks

Each company in this group has been selected because it either owns substantial proprietary content, provides technology to facilitate content licensing, or supports the increased computational demand this shift will create. They're the gatekeepers and enablers of the AI data economy.

Why You'll Want to Watch These Stocks

💰

New Revenue Stream Alert

These companies can now monetize what was previously given away for free. By charging AI developers for access to their content, they're creating entirely new, high-margin revenue opportunities overnight.

🔄

Power Shift Happening Now

Cloudflare's decision to block AI crawlers by default has tilted the balance of power from AI companies to content owners. This fundamental market shift could reshape how value is distributed across the internet economy.

🚀

Early Stage Opportunity

The AI data licensing market is just beginning to form. These companies are positioned at the ground floor of what could become a massive new economic layer of the internet, with first-mover advantages.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions